Learn More
Medchemexpress LLC Azd-1480 | 935666-88-9 | MFCD16038904 | 99.9% | 348.76 g/mol | C14H14ClFN8 | 100 MG

Supplier: Medchemexpress LLC HY10193100MG
AZD-1480 is a small-molecule, ATP-competitive inhibitor of Janus kinases JAK1 and JAK2 developed for research use to block JAK/STAT signaling. It exhibits potent biochemical inhibition of JAK2 and reduces STAT3 phosphorylation in cellular models, producing antiproliferative effects in JAK-dependent cell lines.
- ATP-competitive inhibitor of JAK1 and JAK2.
- High biochemical potency (JAK2 Ki ≈ 0.26 nM; JAK1 IC50 ≈ 1.3 nM reported).
- Inhibits STAT3 phosphorylation and downstream signaling in cells.
- Demonstrates antiproliferative activity in JAK-dependent cell models.
- Supplied as a high-purity research compound for in vitro and in vivo studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.